Company Filing History:
Years Active: 2009
Title: Innovator Stephen D. Johnston: A Pioneer in Breast Cancer Research
Introduction: Stephen D. Johnston, an accomplished inventor located in Wheaton, IL, has made significant contributions to the field of breast cancer research. He is recognized primarily for his innovative work surrounding the estrogen-related receptor alpha (ERRα) and its implications in breast cancer prognosis and treatment.
Latest Patents: Johnston holds a patent titled "Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer." This groundbreaking invention identifies ERRα as a critical breast cancer biomarker, indicating the clinical course and treatment sensitivity of the disease. A high level of ERRα in breast cancer cases suggests poor prognosis. The patent reveals that analyzing ERRα expression, in conjunction with the status of ERα and ErbB2, can assist breast cancer patients in making informed treatment choices. Moreover, the invention proposes that breast cancer can be treated effectively by modulating ERRα activity.
Career Highlights: Stephen D. Johnston is associated with the Wisconsin Alumni Research Foundation, where he collaborates with other leading scientists on impactful research projects. His patent work showcases his dedication to improving the lives of breast cancer patients and advancing the field of medical research.
Collaborations: Johnston has worked alongside esteemed colleagues including Janet E. Mertz and Richard J. Kraus. Their collective efforts reflect a commitment to innovation and enhancing understanding in breast cancer treatment.
Conclusion: Stephen D. Johnston's contributions to breast cancer research underscore his status as an influential inventor. His pioneering patent on ERRα not only facilitates better prognostic assessments but also opens new avenues for therapeutic targets in the fight against breast cancer. As research progresses, Johnston's work will undoubtedly play a significant role in shaping future treatment strategies.